Zweig-DiMenna Associates LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zweig-DiMenna Associates LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$329,734
-11.2%
320,1300.0%0.04%
-15.2%
Q2 2023$371,351
+102.2%
320,130
+163.2%
0.05%
+84.0%
Q1 2023$183,661
-47.8%
121,630
-13.6%
0.02%
-51.0%
Q4 2022$352,125
-40.7%
140,8500.0%0.05%
-60.5%
Q3 2022$594,000
+312.5%
140,850
+173.5%
0.13%
+377.8%
Q2 2022$144,000
-51.2%
51,5000.0%0.03%
-30.8%
Q1 2022$295,00051,5000.04%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders